| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.33▲ | 2.33▲ | 2.33▲ | 2.29▲ | 2.32▲ |
| MA10 | 2.27▲ | 2.25▲ | 2.25▲ | 2.34▲ | 2.10▲ |
| MA20 | 2.21▲ | 2.24▲ | 2.28▲ | 2.27▲ | 2.01▲ |
| MA50 | 2.28▲ | 2.45▲ | 2.44▲ | 2.05▲ | 2.04▲ |
| MA100 | 2.47▼ | 2.28▲ | 2.18▲ | 2.00▲ | 1.84▲ |
| MA200 | 2.35▲ | 2.14▲ | 2.10▲ | 2.03▲ | 1.56▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.037▲ | 0.038▲ | 0.029▲ | -0.013▼ | 0.061▲ |
| RSI | 69.633▲ | 61.190▲ | 59.900▲ | 59.796▲ | 58.735▲ |
| STOCH | 90.216▲ | 90.878▲ | 81.904▲ | 31.365 | 46.891 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -59.036 | -41.176 |
| CCI | 199.437▲ | 205.367▲ | 202.215▲ | 14.033 | 107.844▲ |
|
Thursday, October 23, 2025 06:58 AM
Investing.com -- Entera Bio Ltd. (NASDAQ:ENTX) stock rose 3.5% in Thursday’s premarket trading following the company’s presentation of new clinical data from its Phase 2 trial of EB613, an oral ...
|
|
Thursday, October 23, 2025 06:18 AM
Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10 years post-menopause Data further support EB613 potential as a ...
|
|
Thursday, October 16, 2025 05:58 AM
First-time presentation examining bone outcomes in early postmenopausal womenJERUSALEM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/10/25 | 2.39 | 2.46 | 2.39 | 2.46 | 109,960 |
| 27/10/25 | 2.22 | 2.37 | 2.20 | 2.33 | 199,180 |
| 24/10/25 | 2.13 | 2.2699 | 2.13 | 2.22 | 86,873 |
| 23/10/25 | 2.41 | 2.43 | 2.12 | 2.14 | 2,533,853 |
| 22/10/25 | 2.38 | 2.38 | 2.25 | 2.30 | 57,019 |
| 21/10/25 | 2.51 | 2.51 | 2.3201 | 2.39 | 42,820 |
| 20/10/25 | 2.36 | 2.53 | 2.36 | 2.47 | 73,257 |
| 17/10/25 | 2.42 | 2.4302 | 2.25 | 2.35 | 61,831 |
| 16/10/25 | 2.46 | 2.51 | 2.34 | 2.41 | 86,149 |
| 15/10/25 | 2.45 | 2.50 | 2.27 | 2.38 | 247,324 |
|
|
||||
|
|
||||
|
|